Bertus Eksteen
- Hepatology top 0.5%
- Liver Diseases and Immunity 33
- Immunology top 1%
- T-cell and B-cell Immunology 15
- Immune Cell Function and Interaction 12
- Immunotherapy and Immune Responses 8
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 21
- Microscopic Colitis 9
- Immunology and Allergy top 5%
- Gastroenterology top 5%
-
- Inflammatory Bowel Disease 18
-
- Gallbladder and Bile Duct Disorders 11
- Co-authors
- David AdamsStuart M. CurbishleyGilaad G. KaplanPatricia F. LalorJ. Rodrigo MoraUlrich H. von AndrianAlice MilesSi‐Young Song
- Cited by
- HepatologyImmunologyEpidemiology
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
Bertus Eksteen
78 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Hepatology 1.4k
- Immunology 1.9k
- Epidemiology 1.4k
- Immunology and Allergy 180
- Gastroenterology 150
Countries citing papers authored by Bertus Eksteen
This map shows the geographic impact of Bertus Eksteen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertus Eksteen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertus Eksteen more than expected).
Fields of papers citing papers by Bertus Eksteen
This network shows the impact of papers produced by Bertus Eksteen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertus Eksteen. The network helps show where Bertus Eksteen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bertus Eksteen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 22 | |
| 3 | 2020 | 35 | |
| 4 | The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC. | 2019 | 3 |
| 5 | 2017 | 19 | |
| 6 | 2016 | 48 | |
| 7 | Hepatic expression of lysyl oxidase-like-2 ( LOXL2) in primary sclerosing cholangitis (PSC) | 2016 | 3 |
| 8 | 2016 | 16 | |
| 9 | 2016 | 20 | |
| 10 | 2015 | 22 | |
| 11 | 2015 | 29 | |
| 12 | 2014 | 5 | |
| 13 | 2014 | 108 | |
| 14 | 2012 | 166 | |
| 15 | 2010 | 177 | |
| 16 | 2010 | 40 | |
| 17 | 2009 | 37 | |
| 18 | 2008 | 49 | |
| 19 | 2006 | 139 | |
| 20 | 2004 | 245 |
About Bertus Eksteen
Bertus Eksteen is a scholar working on Hepatology, Immunology, Epidemiology, Genetics and Surgery, having authored 80 papers that have together received 4.6k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (33 papers), Liver Disease Diagnosis and Treatment (21 papers), Inflammatory Bowel Disease (18 papers), T-cell and B-cell Immunology (15 papers), Immune Cell Function and Interaction (12 papers), Gallbladder and Bile Duct Disorders (11 papers), Microscopic Colitis (9 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Hepatology (1.4k citations), Immunology (1.9k citations), Epidemiology (1.4k citations), Immunology and Allergy (180 citations) and Gastroenterology (150 citations). Bertus Eksteen has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include David Adams, Stuart M. Curbishley, Gilaad G. Kaplan, Patricia F. Lalor, J. Rodrigo Mora, Ulrich H. von Andrian, Alice Miles, Si‐Young Song, Aya Yokota and Paola Ricciardi‐Castagnoli. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Hepatology, Gut and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.